Resources
European AI Compliance: Why the Regulatory Timeline May Already Change
European AI compliance is entering a new phase. While organizations are only beginning to implement the requirements of the European Union’s Artificial Intelligence Act (AI
Clinical Trial Recruitment Challenges in Europe: Why Is Patient Enrollment Becoming More Difficult?
Clinical trial recruitment challenges in Europe have become a major concern for pharmaceutical companies, CROs, hospitals, medical device manufacturers, and health authorities. Today, many clinical
AI-Driven Drug Discovery: Towards a New Acceleration of Pharmaceutical Innovation?
AI-driven drug discovery is gradually emerging as one of the major transformation trends in the pharmaceutical industry. Over the past few years, major pharmaceutical companies,
COVID-19 Vaccines: Which Procedures Were Really Accelerated in Europe?
The extremely rapid development of COVID-19 vaccines deeply influenced public opinion. Between the identification of SARS-CoV-2 in early 2020 and the first vaccination campaigns in
EUDAMED: Complete Guide to the European Database on Medical Devices
The progressive implementation of EUDAMED represents one of the major changes introduced by the European MDR 2017/745 regulation. Designed as a central tool for transparency,
Low-Intervention Clinical Trials: An Underused Opportunity in Europe?
Low-intervention clinical trials occupy a unique position within the European Clinical Trials Regulation. Designed to simplify certain studies involving already authorized medicines, these trials were
